WITHDRAWN: The comparison of the effectiveness of lincocin® and azitro® in the treatment of covid-19-associated pneumonia: A prospective study

J Popul Ther Clin Pharmacol. 2020 Jun 3;27(S Pt 1):e5-e10. doi: 10.15586/jptcp.v27iSP1.684.

Abstract

For legal reasons, the publisher has withdrawn permission for online, public display of this record in PubMed. For additional information, please contact the publisher.

Keywords: COVID-19; coronavirus; medication; pneumonia; treatment.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Azithromycin / administration & dosage
  • Azithromycin / adverse effects
  • Azithromycin / therapeutic use*
  • Betacoronavirus
  • Bronchoalveolar Lavage Fluid / virology
  • COVID-19
  • Coronavirus Infections / complications*
  • Female
  • Humans
  • Lincomycin / administration & dosage
  • Lincomycin / adverse effects
  • Lincomycin / therapeutic use*
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonia, Viral / complications
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / etiology
  • Pneumonia, Viral / virology
  • Prospective Studies
  • Risk Factors
  • SARS-CoV-2

Substances

  • Anti-Bacterial Agents
  • Azithromycin
  • Lincomycin